1. Arnaud JP, Buyse M, Nordlinger B, et al. Adjuvant therapy of poor prognosis colon cancer with levamisole: results of an EORTC double-blind randomized clinical trial. Br J Surg 1989;76:284–9.
2. Berlin J, Posey J, Tchekmedyian S, et al. Panitumumab with irino-tecan/leucovorin/5-fluorouracil for first-line treatment of meta-static colorectal cancer. Clin Colorectal Cancer 2007;6:427–32.
3. Bokemeyer C, Bondarenko I, Makhson A, et al. Cetuximab plus 5-FU/FA/Oxaliplatin (FOLFOX-4) versus FOLFOX-4 in the first-line treatment of metastatic colorectal cancer: OPUS, a randomized phase II study. Proc Am Soc Clin Oncol 2007;25:172s [abstract 4035].
4. Bonnem EM, Spiegel RJ. Interferon-alpha: current status and future promise. J Biol Response Mod 1984; 3:580–8.
5. Cascinu S, Catalano V, Piga A, et al. The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone. Cancer Invest 2003;21:701–7.